These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7645108)

  • 21. Scandinavian simvastatin study (4S).
    Grodos D; Tonglet R
    Lancet; 1994 Dec 24-31; 344(8939-8940):1768. PubMed ID: 7997017
    [No Abstract]   [Full Text] [Related]  

  • 22. Statins and coronary artery disease--it's the clinical endpoints that count.
    Jackson G
    Br J Clin Pract; 1997; 51(1):2-3. PubMed ID: 9158261
    [No Abstract]   [Full Text] [Related]  

  • 23. Scandinavian simvastatin study (4S).
    Stalenhoef AF
    Lancet; 1994 Dec 24-31; 344(8939-8940):1766-7; author reply 1767-8. PubMed ID: 7997015
    [No Abstract]   [Full Text] [Related]  

  • 24. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives.
    McKenna CJ; Sugrue DD
    Ir Med J; 1995; 88(6):191. PubMed ID: 8575912
    [No Abstract]   [Full Text] [Related]  

  • 25. The statin trials: closing arguments in the case against cholesterol?
    Gaw A
    Scott Med J; 1996 Aug; 41(4):99-100. PubMed ID: 8873306
    [No Abstract]   [Full Text] [Related]  

  • 26. Cholesterol-lowering, simvastatin, and coronary heart disease.
    Gram J; Jespersen J
    Lancet; 1995 Mar; 345(8949):592. PubMed ID: 7776806
    [No Abstract]   [Full Text] [Related]  

  • 27. Beneficial effects of simvastatin may be due to non-lipid actions.
    Ravnskov U
    BMJ; 1995 Nov; 311(7017):1436-7. PubMed ID: 8520302
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 29. The 4S study: a critical review.
    Crepaldi G
    Pharmacol Res; 1997 Mar; 35(3):163. PubMed ID: 9229400
    [No Abstract]   [Full Text] [Related]  

  • 30. [Data on cholesterol level screening of patients with ischemic heart disease in the light of the Scandinavian Simvastatin Survival Study].
    Márk L; Kondacs A; Hanyecz V; Simondán G
    Orv Hetil; 1997 Jun; 138(26):1679-82. PubMed ID: 9289681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current developments in prevention of coronary heart disease].
    Windler E
    Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin in the media.
    Watt G; Galbraith W
    N Z Med J; 1989 Dec; 102(881):651-2. PubMed ID: 2608245
    [No Abstract]   [Full Text] [Related]  

  • 33. Lowering patients' cholesterol. Extrapolating results of trial of simvastatin gives room for doubt.
    Hippisley-Cox J
    BMJ; 1995 Sep; 311(7006):690-1. PubMed ID: 7549665
    [No Abstract]   [Full Text] [Related]  

  • 34. [Statin therapy of individuals with high risk for coronary disease].
    Holme I
    Tidsskr Nor Laegeforen; 1996 May; 116(12):1479-81. PubMed ID: 8650638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol lowering does have a role in secondary prevention.
    Wood DA
    Br Heart J; 1995 Jan; 73(1):4-5. PubMed ID: 7888259
    [No Abstract]   [Full Text] [Related]  

  • 36. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
    Haffner SM
    Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961
    [No Abstract]   [Full Text] [Related]  

  • 37. The 4S study and its pharmacoeconomic implications.
    Reckless JP
    Pharmacoeconomics; 1996 Feb; 9(2):101-5. PubMed ID: 10172696
    [No Abstract]   [Full Text] [Related]  

  • 38. Statins and coronary heart disease.
    Oliver MF
    Lancet; 1996 Jul; 348(9019):57. PubMed ID: 8691943
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lowering LDL cholesterol with Simvastatin. Also, economically reasonable!].
    Internist (Berl); 1995 Aug; 36(8 Suppl):1-4. PubMed ID: 9131077
    [No Abstract]   [Full Text] [Related]  

  • 40. Doctors, research funds and marketing.
    Colquhoun DM
    Med J Aust; 1995 Jun; 162(12):670, 672. PubMed ID: 7603388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.